Physician's Center For Weight Management

Physician's Center For Weight Management in Oklahoma City, Oklahoma, operates under the medical direction of Dr. Lee Frye, MD FACOG, a board-certified physician with credentials from the American Board of Obesity Medicine. Dr. Frye brings dual expertise in obstetrics and gynecology alongside specialized training in obesity medicine, positioning the clinic to address the complex interplay between hormonal health and metabolic function. This Oklahoma City practice focuses exclusively on medically supervised weight management programs that integrate pharmaceutical interventions, hormone optimization, and nutritional counseling into individualized treatment protocols.

The clinic offers GLP-1 receptor agonist therapies including tirzepatide and semaglutide as cornerstone treatments for patients with obesity or weight-related metabolic conditions. Tirzepatide functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, demonstrating superior weight reduction outcomes in clinical trials compared to single-pathway medications. Semaglutide, a GLP-1 analog, works by slowing gastric emptying, reducing appetite signaling in the hypothalamus, and improving glycemic control in patients with insulin resistance. These peptide therapies are prescribed following comprehensive metabolic assessment and are monitored throughout treatment to optimize dosing and manage potential side effects. The clinic's approach extends beyond pharmaceutical intervention to include hormone therapy evaluation, recognizing that thyroid dysfunction, sex hormone imbalances, and cortisol dysregulation frequently contribute to treatment-resistant weight gain.

Dr. Frye's background in women's health informs the clinic's understanding of weight management challenges across reproductive life stages, including postpartum weight retention, perimenopausal metabolic shifts, and post-hysterectomy hormonal changes. The American Board of Obesity Medicine certification requires physicians to demonstrate advanced knowledge in adipose tissue biology, pharmacotherapy for obesity, behavioral modification strategies, and the medical complications of excess weight. This specialized training enables the clinic to identify and address underlying metabolic disorders such as polycystic ovary syndrome, hypothyroidism, and insulin resistance that complicate weight loss efforts. Patients receive structured nutrition guidance that aligns with their prescribed peptide therapy, as dietary composition significantly influences treatment response and sustainability of weight loss outcomes.

Patients at Physician's Center For Weight Management in Oklahoma City attend in-person consultations where Dr. Frye conducts initial assessments including body composition analysis, metabolic panel review, and evaluation of weight-related comorbidities such as hypertension, dyslipidemia, and sleep apnea. The clinic establishes baseline measurements and sets realistic weight reduction targets based on individual metabolic profiles rather than applying standardized protocols. Follow-up appointments track progress through objective metrics including weight trends, waist circumference changes, blood pressure normalization, and improvements in lipid panels or hemoglobin A1c levels. Patients receive education on recognizing and managing common side effects of GLP-1 therapies, including nausea, constipation, and the importance of adequate protein intake to preserve lean muscle mass during caloric restriction.

With a 4.2-star rating across 24 Google reviews, the clinic serves Oklahoma City residents seeking physician-supervised alternatives to commercial diet programs or bariatric surgery. The practice's focus on the medical aspects of weight management distinguishes it from wellness centers offering weight loss as an ancillary service. Dr. Frye's dual board certifications allow the clinic to address the specific needs of women experiencing hormonally-mediated weight gain while providing evidence-based peptide therapies that have demonstrated efficacy in large-scale clinical trials. The in-person consultation model ensures direct physician oversight of medication titration and enables real-time adjustment of treatment plans based on patient response and tolerance.